117 related articles for article (PubMed ID: 8615500)
1. Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine.
Karan SM; Lojeski EW; Haynes DH; Bina S; Wesche DL; Boedeker BH; Muldoon SM
Anesth Analg; 1996 Apr; 82(4):796-802. PubMed ID: 8615500
[TBL] [Abstract][Full Text] [Related]
2. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
Flewellen EH; Nelson TE
Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
[TBL] [Abstract][Full Text] [Related]
3. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
Flewellen EH; Nelson TE; Bee DE
Can Anaesth Soc J; 1980 Jan; 27(1):16-21. PubMed ID: 7353186
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
5. Dantrolene in porcine malignant hyperthermia.
Gronert GA; Milde JH; Theye RA
Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
[TBL] [Abstract][Full Text] [Related]
6. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Menge M; Schulte Am Esch J
Anesthesiology; 2003 Nov; 99(5):1132-6. PubMed ID: 14576550
[TBL] [Abstract][Full Text] [Related]
7. Azumolene reverses episodes of malignant hyperthermia in susceptible swine.
Dershwitz M; Sréter FA
Anesth Analg; 1990 Mar; 70(3):253-5. PubMed ID: 2305975
[TBL] [Abstract][Full Text] [Related]
8. Dantrolene in human malignant hyperthermia.
Kolb ME; Horne ML; Martz R
Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
[TBL] [Abstract][Full Text] [Related]
9. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
Harrison GG
S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
[TBL] [Abstract][Full Text] [Related]
10. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
Hall GM; Lucke JN; Orchard C; Lovell R; Lister D
Anaesthesia; 1982 Dec; 37(12):1167-70. PubMed ID: 7181063
[TBL] [Abstract][Full Text] [Related]
11. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
Alitalo I; Schulman A
Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
[TBL] [Abstract][Full Text] [Related]
12. The novel rapid formulation of intravenous dantrolene (NPJ5008) versus standard dantrolene (Dantrium®): A clinical part-randomised phase 1 study in healthy volunteers.
Ng Kwet Shing RH; Clayton LB; Smith SL; Watson MJ; McKenzie LM; Chalmers DP; Whitaker G; Bilmen JG
Eur J Anaesthesiol; 2024 May; 41(5):381-390. PubMed ID: 38445365
[TBL] [Abstract][Full Text] [Related]
13. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
[TBL] [Abstract][Full Text] [Related]
14. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
Harrison GG
Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
[TBL] [Abstract][Full Text] [Related]
15. In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium.
Verburg MP; Oerlemans FT; van Bennekom CA; Gielen MJ; de Bruyn CH; Crul JF
Acta Anaesthesiol Scand; 1984 Feb; 28(1):1-8. PubMed ID: 6711253
[TBL] [Abstract][Full Text] [Related]
16. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
Nelson TE; Flewellen EH
Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
[TBL] [Abstract][Full Text] [Related]
17. Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?
Podranski T; Bouillon T; Schumacher PM; Taguchi A; Sessler DI; Kurz A
Anesth Analg; 2005 Dec; 101(6):1695-1699. PubMed ID: 16301243
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
[TBL] [Abstract][Full Text] [Related]
19. The reduction of skeletal muscle lesions after experimental stress in stress-susceptible pigs protected with dantrolene.
Bjurström S; Carlsten J; Jönsson L
Zentralbl Veterinarmed A; 1995 Dec; 42(10):659-67. PubMed ID: 8822190
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia with excellent response to small dose of dantrolene.
Chang KY; Ting CK; Chan KH; Tsai SK
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
